E. John Steren

John Steren, Epstein Becker Law Firm, Health Care Litigation Attorney

E. John Steren
Epstein Becker & Green, P.C.
Member
202-861-1825
Website
www.ebglaw.com
Organization Profile Full Profile
Connect
- Email

Professional Biography:

E. John Steren is a Member of the Firm in the Health Care & Life Sciences and Litigation & Business Disputes practices, in the Washington, DC, office of Epstein Becker Green. Mr. Steren devotes a significant portion of his practice to helping health care organizations manage the antitrust risks of joint ventures and other business arrangements. He also focuses his practice on other complex commercial and civil litigation matters.

Articles in the National Law Review database by E. John Steren

Final Listening Forum on Firsthand Effects of Mergers and Acquisitions to Be Held on May 12, 2022 (Posted On Thursday, May 5, 2022)
What Happens When Parties Abandon a Transaction Challenged by the FTC? (Posted On Thursday, April 21, 2022)
American Hospital Association Pushes for Updates to Merger Guidelines (Posted On Thursday, April 7, 2022)
FTC and DOJ to Hold Listening Forums on Merger Experience (Posted On Thursday, March 24, 2022)
Return of Early Termination of the HSR Waiting Period Not on the FTC’s Agenda, According to Commissioner Phillips (Posted On Thursday, March 10, 2022)
Antitrust Enforcers Continue March to Protect Labor Markets in Health Care and Other Industries (Posted On Thursday, February 10, 2022)
FTC and DOJ Seek Public Comments on Merger Guidelines (Posted On Thursday, January 27, 2022)
Hospital Transactions Subject to Hart-Scott-Rodino Reporting Obligations See Dramatic Rise in Second Requests for Information (Posted On Thursday, December 2, 2021)
How Will Biden’s Executive Order Impact Future Hospital Mergers? [PODCAST] (Posted On Monday, November 22, 2021)
Commissioner Wilson Issues Strong Comments to Antitrust Bar (Posted On Thursday, November 18, 2021)
Federal Trade Commission Continues Quest to Stem the Merger Tide (Posted On Thursday, November 4, 2021)
FTC Announces Proposed Changes to Second Request Process, But... (Posted On Thursday, October 21, 2021)
A Divided FTC Withdraws 2020 Vertical Guidelines, Introducing Uncertainty into Review of Vertical Mergers (Posted On Monday, September 20, 2021)
Medical Device Manufacturers, Beware: FTC Ramps Up Enforcement Against Repair Restrictions (Posted On Thursday, August 26, 2021)
FTC Responds to Tsunami of HSR Filings (Posted On Thursday, August 12, 2021)
FTC Reinstates Notice and Approval Requirements in All Merger Settlement Agreements (Posted On Thursday, July 29, 2021)
Biden Issues Executive Order Promoting Competition (Posted On Thursday, July 15, 2021)
Lina Khan Takes Charge of the Federal Trade Commission (Posted On Thursday, June 24, 2021)
Focus on Antitrust in Health Care Transactions (Posted On Thursday, June 10, 2021)
Public Comment Period on Pharmaceutical Mergers Opens and Exposes Dueling Philosophies Among FTC Commissioners (Posted On Thursday, May 20, 2021)

Pages

FTC Regulation

FTC Coverage and Updates

The National Law Review awards Epstein Becker & Green attorneys E. John Steren and Patricia M. Wagner with a Go-To Thought Leadership award for their coverage of a range of competition law topics including personnel changes at the FTC and the large uptick in Hart-Scott-Rodino (“HSR”) filings the FTC received in 2021. Exceptionally helpful to the NLR's readers in 2021 were Mr. Steren's & Ms. Wagner's actionable insights on how the new direction at the FTC impacts the pharmaceutical and healthcare industries.